Hip Replacement News and Research RSS Feed - Hip Replacement News and Research

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types. [More]
Researchers design new model to identify promising candidates for total hip replacement surgery

Researchers design new model to identify promising candidates for total hip replacement surgery

Researchers at Sahlgrenska Academy have designed a new model to help doctors and patients decide whether or not to proceed with total hip replacement surgery. The researchers have also surveyed patient wellbeing after surgery: patients with high education achieve greater outcome scores, while those with antidepressant prescriptions do not. [More]
Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Mayo Clinic Hospitals in Rochester, Minn, and Phoenix earned the top-tier High Performing distinction in all five common care categories in the latest ratings by U.S. News & World Report. [More]
Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

U.S. News & World Report, publisher of Best Hospitals and Best Children's Hospitals, today announced that Kaiser Permanente and Intermountain Healthcare will participate in the U.S. News Hospital Outcome Data Disclosure Program, a new data-collection initiative designed to evaluate hospitals more completely and give patients better information about the hospitals in their communities. [More]
Boehringer Ingelheim seeks FDA approval for Pradaxa to treat DVT and PE

Boehringer Ingelheim seeks FDA approval for Pradaxa to treat DVT and PE

Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE. [More]
Radlink, DePuy Synthes sign exclusive worldwide sales agency agreement

Radlink, DePuy Synthes sign exclusive worldwide sales agency agreement

Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide. [More]
Penn surgeons develop new tools to identify joint replacement patients at risk for serious complications

Penn surgeons develop new tools to identify joint replacement patients at risk for serious complications

Orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania have developed two new prediction tools aimed at identifying total hip and knee replacement patients who are at-risk of developing serious complications after surgery. [More]
Bariatric surgery prior to joint replacement improves outcomes in obese patients

Bariatric surgery prior to joint replacement improves outcomes in obese patients

Obesity is not only a risk factor for developing knee and hip arthritis. It is also linked to less favorable outcomes after joint replacement surgery. [More]
DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies’ ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs. [More]
Zimmer celebrates significant testing milestone for Vivacit-E Vitamin E Technology

Zimmer celebrates significant testing milestone for Vivacit-E Vitamin E Technology

Zimmer Holdings, Inc. is highlighting its Vivacit-E Advanced Bearing Technology with Vitamin E by celebrating a significant testing milestone. [More]
Hip replacement procedure alleviates pain, improves function in young JIA patients

Hip replacement procedure alleviates pain, improves function in young JIA patients

Hip replacement is often performed in patients with juvenile arthritis when their joints have been severely damaged by the disease. [More]

Patients who undergo THR may safely drive by 2 weeks after surgery

Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). [More]
Cost of care for benign prostate hyperplasia measured for the first time

Cost of care for benign prostate hyperplasia measured for the first time

UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition. [More]
NHS savings plan led to cuts in some ‘ineffective’ treatments

NHS savings plan led to cuts in some ‘ineffective’ treatments

The drive to reduce NHS spending led to a drop in some treatments considered ‘low-value’, according to new research. [More]
NYU Langone becomes first center in New York City to start outpatient hip replacement program

NYU Langone becomes first center in New York City to start outpatient hip replacement program

NYU Langone Medical Center in January became the first academic medical center in the New York City area to initiate an outpatient hip replacement program after successfully discharging a patient the same day of surgery. [More]
Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

Researchers at Boston Medical Center have found that the expansion of insurance coverage in Massachusetts increased the number of elective knee and hip replacement procedures by 4.7 percent, with greater increases among black and Hispanic patients. [More]
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers with Porous Silicon Nitride Center

Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers with Porous Silicon Nitride Center

Amedica announced today that it has filed a submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding (“Valeo CCsC”) with the U.S. Food and Drug Administration (“FDA”) relating to its composite silicon nitride spinal interbody devices. [More]
St. Mary's wins Distinguished Hospital Award for Clinical Excellence for second consecutive year

St. Mary's wins Distinguished Hospital Award for Clinical Excellence for second consecutive year

Dignity Health St. Mary's Medical Center has received the Distinguished Hospital Award for Clinical Excellence™ from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. This is the second consecutive year St. Mary's has received this award, which recognizes St. Mary's as among the top five percent of more than 4,500 hospitals nationwide for clinical performance. [More]
Orlando Regional Medical Center opens new patient tower

Orlando Regional Medical Center opens new patient tower

As the new year begins, Orlando Health turns the page to a new chapter in patient, guest and team member experience, when Orlando Regional Medical Center opens its new patient tower. [More]
Total hip replacement: An excellent option for younger patients with juvenile idiopathic arthritis

Total hip replacement: An excellent option for younger patients with juvenile idiopathic arthritis

When you think of hip replacement surgery, you generally envision an older adult with painful osteoarthritis. But the procedure is also used for younger patients with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the disease. [More]
Advertisement
Advertisement